Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
GENESIS AI CORP. | NL8 | Nov 26, 2024 | 0.02 | 0.00 |
GENESIS MINERALS LTD | 3G2 | Nov 26, 2024 | 1.45 | 0.00 |
Genetic Analysis | 8V8 | Nov 26, 2024 | 0.03 | +33.00 |
Genetic Technologies ADR | DU80 | Nov 26, 2024 | 0.69 | 0.00 |
Genetic Technologies Ltd. | DU8 | Nov 26, 2024 | 0.05 | 0.00 |
GeNeuro SA | GEM | Nov 26, 2024 | 0.05 | +1.32 |
Genfit | XUP | Nov 26, 2024 | 4.04 | -0.37 |
GENFIT S.A. - American Depositary Shares | XUPB | Nov 26, 2024 | 3.92 | +1.03 |
Genflow Biosciences Plc | WQ5 | Nov 26, 2024 | 0.02 | -7.50 |
Genie Energy Ltd. Class B | 6GE | Nov 26, 2024 | 15.50 | +0.65 |
GENinCode plc | 9PL | Nov 26, 2024 | 0.05 | 0.00 |
Genius Metals Inc. | 0FU | Nov 26, 2024 | 0.05 | -1.05 |
Genmab | GE9 | Nov 26, 2024 | 195.45 | -1.96 |
Genmab A/S - American Depositary Shares | GE91 | Nov 26, 2024 | 19.80 | +0.51 |
Genomma Lab Internacional SAB | GEKA | Nov 26, 2024 | 1.15 | -4.17 |
Genomtec S.A. | 4VI | Nov 26, 2024 | 1.45 | +0.41 |
Genor Biopharma Holdings Limited | 67N0 | Nov 26, 2024 | 0.15 | -1.28 |
Genovis | 5GV | Nov 26, 2024 | 2.34 | -1.89 |
Genoway | JEH | Nov 26, 2024 | 3.54 | 0.00 |
Genpact Ltd | 35G | Nov 26, 2024 | 44.45 | +1.37 |
Genscript Biotech Corporation | G51 | Nov 26, 2024 | 1.26 | -1.56 |
GenSight Biologics S.A. | G49N | Nov 26, 2024 | 0.27 | -2.18 |
Gensource Potash Corp | UGN | Nov 26, 2024 | 0.04 | -1.23 |
Gentex Corporation | GTX | Nov 26, 2024 | 29.60 | +2.07 |
Gentherm Inc | QA4A | Nov 26, 2024 | 40.20 | -0.99 |
Gentian Diagnostics | 6FK | Nov 26, 2024 | 3.38 | -2.31 |
GENTILI MOSCONI S.P.A | Z5A | Nov 26, 2024 | 2.20 | 0.00 |
GENTING SINGAPORE LTD Ordinary Shares | 36T | Nov 26, 2024 | 0.53 | 0.00 |
Genuine Parts Company | GPT | Nov 26, 2024 | 124.25 | +4.46 |
Genuit Group Plc | 0P5 | Nov 26, 2024 | 4.76 | -0.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.